Genprex GNPX Q1 2026 Earnings Continued RD Investment as Gene Therapy Pipeline Progresses PUK Q4 2025 Earnings EPS Misses Estimates by 2917 Amid Market Headwinds TREX Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency CDZI Q1 2026 Earnings EPS Surprises to the Upside Despite No Reported Revenue SPME Q1 2026 Earnings EPS Misses Estimates Preferred Shares Dip OrthoPediatrics Corp KIDS Holds Steady Near Resistance Eyes Breakout Potential FutureCrest Acquisition Corp FCRS Edges Higher as Stock Consolidates Between Key Levels Canopy Growth CGC Inches Higher as Cannabis Stock Tests Key Resistance Gladstone Land Preferred Stock LANDO Holds Steady Near Support as Income Seekers Eye Yield BillionToOne Inc BLLN Q1 2026 Earnings Significant EPS Beat Surprises Markets Yet Stock Declines